GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: RP-54476 | RP54476 | Synercid® (dalfopristin + quinupristin)
dalfopristin is an approved drug (FDA (1999))
Compound class:
Synthetic organic
Comment: Dalfopristin is a semi-synthetic derivative of pristinamycin IIA (streptogramin A). It inhibits the early phase of protein synthesis in the bacterial ribosome by binding to the 70S subunit. It is administered intravenously.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. US FDA (1999) |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 6581 | dalfopristin |
Synonyms ![]() |
| RP-54476 | RP54476 | Synercid® (dalfopristin + quinupristin) |
Database Links ![]() |
|
| Specialist databases | |
Antibiotic DB
|
Dalfopristin | Quinupristin/dalfopristin (Synercid) |
| Other databases | |
| CAS Registry No. | 112362-50-2 (source: WHO INN record) |
| GtoPdb PubChem SID | 405560238 |
| PubChem CID | 6323289 |
| RCSB PDB Ligand | DOL |
| Search Google for chemical match using the InChIKey | SUYRLXYYZQTJHF-VMBLUXKRSA-N |
| Search Google for chemicals with the same backbone | SUYRLXYYZQTJHF |
| Search PubMed clinical trials | dalfopristin |
| Search PubMed titles | dalfopristin |
| Search PubMed titles/abstracts | dalfopristin |
| UniChem Compound Search for chemical match using the InChIKey | SUYRLXYYZQTJHF-VMBLUXKRSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | SUYRLXYYZQTJHF-VMBLUXKRSA-N |